Capital Analysts LLC’s Verona Pharma VRNA Stock Holding History

Capital Analysts LLC’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-318	Closed	-$34K	–	1507
2025 Q3	$34K	Hold	318	–	–	﹤0.01%	959
2025 Q2	$30K	Hold	318	–	–	﹤0.01%	920
2025 Q1	$20K	Buy	+318	New	+$19K	﹤0.01%	1002

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Capital Analysts LLC's VRNA Position: Q4 2025 in Review

Capital Analysts LLC sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 318 shares — an estimated $34K sold.

Capital Analysts LLC first reported a position in VRNA in Q1 2025 and held it in 3 quarters. The position peaked at $34K in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Capital Analysts LLC reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Capital Analysts LLC sold 318 Verona Pharma shares in Q4 2025, an estimated $34K.
Capital Analysts LLC first reported a position in Verona Pharma in Q1 2025 and held it in 3 quarters.
Capital Analysts LLC's Verona Pharma position peaked at $34K in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Capital Analysts LLC's 13F filing for Q4 2025, filed 11 Feb 2026.